Second Affiliated Hospital Of Guangxi Medical University

This study tests whether giving a second drug, tirofiban, soon after the standard clot-busting drug tenecteplase can improve outcomes for people with acute ischemic stroke. About 348 adults who had a stroke and received tenecteplase will be enrolled. The goal is to see if the com…